What is EVOTF's gross margin?

Evotec SE (EVOTF) has a gross margin of -1% and a net margin of -33%.

What is EVOTF's P/E ratio?

Track Evotec SE (EVOTF) P/E ratio, ROE, and valuation metrics over time.

Where can I see EVOTF's full financials?

See Evotec SE (EVOTF) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Evotec SE (EVOTF) Financials — Revenue, Earnings, Cash Flow

Also trades as: EVT.DE (XETRA) · $vol 3M · EVT.SW (SIX) · $vol 1M · 0IRF.IL (IOB) · $vol 0M · EVO (NASDAQ) · $vol 0M

$6.69

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 56 · $1.2B mcap · 148M float · 0.0000% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$718M

Revenue

-7.7% YoY

$-197M

Net Income

-27.0% YoY

$-162M

Free Cash Flow

-1400.1% YoY

-1.1%

Gross Margin

-35.6%

Op. Margin

-32.5%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-26.1%

ROA-11.7%

ROIC-14.9%

Valuation

P/E-2.6

P/B0.8

EV/EBITDA0.0

Leverage

Debt/Equity0.71

Current Ratio2.33

Interest Cov.-10.8x

Quality Scores

Piotroski F2/9

Altman Z—

Beneish M-5.68